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• Elekta XVI CBCT: 120 kV, 649 mAs, 649 frames, M20F0, 360° scan  
• Elekta XVI fluoroscopy: 120 kV, AP, 1 mAs per frame, 5.5 Hz frame 
rate, exposure time of 3min, S20F0 
IBC: 
Kawasaki robotic arm with Varian A-277 X-ray tube, B-130H housing 
and Varian PaxScan 4030D flat panel detector:  
• planar kV: AP: 125 kV, 100 mA, 12 ms; LR: 125 kV, 160 mA, 25 ms  
• CBCT: 120 kV, 3 mA, 10 Hz frame rate, 430 frames, scan from -100° 
to +100°  
The energy dependent sensitivity of the TLDs was taken into account 
by corrections based on the respective energy spectrum of the beams. 
Read-out (Harshaw TLD 5500 reader), calibration and annealing of the 
TLDs was performed at the CRD.  
Results: The imaging techniques were grouped in low- and high-dose 
according to the absorbed dose per exam. All results are shown in Fig. 
1. The CBCT at the IBC is included in both graphs to facilitate direct 
comparison. Generally the OAR doses depended on the imaging 
modality and the position of the OARs. The doses for volumetric 
imaging were on average 2.5-130 times higher than for the planar or 
stereoscopic image pairs. The dose caused by a CBCT scan at the CRD 
was ~20 times higher than at the IBC as more projections with higher 
mAs setting were used. The skin dose was higher where the skin was 
closer to the X-ray tube (CBCT) or at the entrance side of the beam 
(anterior, sinister for planar kV; posterior for ExacTrac). The highest 
dose per exam (up to 150 mGy to the skin) originated from the 3 min 
fluoroscopy. 
 
 
 
Conclusions: Imaging modalities like planar kV or stereoscopic 
imaging result in very low doses (<1.6 mGy) to the patient. To assure 
accurate positioning imaging should be performed on a daily basis. 
However, when aiming to image a moving target during irradiation, 
one has to optimize protocols and imaging time, as the induced dose 
to OARs cannot be neglected.  
 
 PROFFERED PAPERS: PHYSICS 2: SMALL FIELD 
CHALLENGES  
 OC-0063   
Commissioning CBCT based Monte Carlo treatment planning system 
for small animal stereotactic irradiation 
R. Pidikiti1, S. Stojadinovic1, S. Kwang1, M. Speiser1, T. Solberg1 
1UTSW Medical Center at Dallas, Radiation Oncology, Dallas, USA  
 
Purpose/Objective: Commissioning a cone beam CT (CBCT)-based 
Monte Carlo treatment planning system for a commercial small animal 
stereotactic irradiator. 
Materials and Methods: The BEAM/EGS Monte Carlo code was used to 
model 225 kV photon beams from a commercial small animal 
stereotactic irradiator (X-RAD 225Cx, Precision X-Ray, North Branford, 
CT). The unit was calibrated in accordance with the recommendations 
of AAPM TG-61. Both in-air and in-water calibrations were performed 
at a 30.5 cm source-to-surface distance (SSD) using a 40x40 mm2 
square reference applicator. The output factors for various applicators 
were measured using various dosimeters (ionization chamber, 
radiochromic film) and compared with MC simulations. The gamma 
index method and AAPM TG 53 recommendations were used to 
benchmark planar radiochromic film measurements against Monte 
Carlo simulations in both homogenous and heterogeneous mediums. 
Benchmarks were performed in both homogeneous and heterogeneous 
media. CBCT calibration curve was created to convert to a CBCT data 
to density matrix. The CBCT images obtained on the XRAD 225Cx 
irradiator were converted to a material /density matrix using CBCT 
calibration curve.The material /density matrix is used as an input to 
DOSXYZnrc for MC dose computation. The measured and MC computed 
absolute doses compared for single and multiple beams in both 
homogenous and heterogenous mediums for 10 mm field size. The 
isodose distributions were compared using the gamma index method 
both for single and multiple beams. 
Results: The in-water and in-air absolute dose measurements 
demonstrated excellent agreement of 3.42 and 3.45 Gy/min, 
respectively. MC and measurement agreement of output factors was 
within 3% for all field sizes. The agreement between simulated and 
measured absolute dose in CBCT based homogeneous medium for 
single and multiple beams was within 1%. In CBCT based 
heterogeneous conditions, it was within 1.5%. Gamma map 
comparisons between MC and measurement with 3% /0.5 mm criteria 
indicating 98% passing rate for 10 mm field size. 
Conclusions: The MC dose calculation in CBCT data was validated in a 
homogenous medium. The comparison between MC and measured dose 
distributions was quantitatively validated using the gamma index 
method for 10 mm field size in CBCT data based homogenous medium. 
A relation was formed between the Monte Carlo dose distributions and 
irradiation absolute dose rate. Finally Monte Carlo calculated absolute 
dose and measured absolute dose in heterogeneous medium are in 
good agreement. 
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Purpose/Objective: A new field of research in radiotherapy is small 
animal image-guided precision radiotherapy. In this, radiotherapy 
procedures are scaled down to the level of structures in small 
animals, to study treatment strategies which may be translated into 
human radiotherapy. To enable this, a combination of high-resolution 
imaging and small field precision irradiation equipment is needed. The 
irradiations need to be downscaled in energy, from megavolt to 
kilovolt energies to avoid extensive buildup regions and beam 
penumbras. To ensure that complex treatments can be delivered, 
mimicking patient treatments, a versatile treatment planning system 
tailored to small animal radiotherapy, is needed, which is unavailable 
currently.  
Materials and Methods: A treatment planning system for small animal 
pre-clinical radiotherapy was developed, named Smart-Plan (Small 
Animal RadioTherapy Planning system). It is capable of planning the 
irradiation of small specimens such as mice or rats with either 
multiple coplanar beams or arcs for 225 kV x-rays. This low photon 
energy mandates careful assignment of the specimen tissues because 
of the strong dependence of the photon interaction coefficients 
(photo-electric effect) on the tissue composition. To this end, the 
micro-CT image from the onboard high-resolution imager is converted 
into a density and composition map, by calibration and visual 
inspection of the material map. Smart-Plan handles accurate beam 
positioning and absolute dose calculation is performed with Monte 
Carlo simulations based on a detailed model of the complete 
irradiator, including an accurate model of the focal spot distribution 
of the primary electron beam hitting the x-ray target. Smart-Plan 
comprises an interface to transfer treatment parameters to the 
irradiator. To speed up the calculation multiple simultaneous 
simulations are performed on a multi-core computer. To validate 
Smart-Plan planned and measured dose distributions in a multislab 
heterogeneous phantom were compared. 
Results:  
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Fig 1 shows a screenshot of Smart-Plan of the module where CT 
images of animal specimens are inspected for their electron density, 
and where a range of tissues is assigned to the very small voxels. The 
bottom panel shows a Monte Carlo dose distribution in a mouse thorax 
from 3 stationary photon beams in the range of 1-5 mm field size. The 
results are presented as dose-to-medium, meaning the photon 
transport was done in the proper media and doses are expressed in 
the media as well (an alternative is to express doses in water). The 
calculation times for a typical treatment plan are about 5 minutes. 
The dose verification in the heterogeneous phantom revealed good 
agreement between measured and calculated dose distributions.  
Conclusions: A novel radiotherapy treatment planning system for 
small animals was developed and validated. The system may play an 
important role in pre-clinical translational studies.  
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Purpose/Objective: Flattening filter free (FFF) beams can can 
improve the delivery of radiotherapy treatments by reducing 
treatment times. The delivery of stereotactic treatments , in 
particular, can greatly benefit from FFF beams as the combination of 
high dose per fraction combined with patient immobilization can 
result in long periods of patient discomfort. However, the small 
treatment fields used in stereotactic treatments and the changes in 
beam spectrum and scattering conditions that occur with a FFF beam 
provides challenging conditions for accurate dosimetry. This study 
aims to assess the performance of a range of dosimeters in an FFF 
beam with particular attention focused on small field dosimetry. The 
dosimeters used were: an ionisation chamber; diodes; an air core fibre 
optic dosimeter (FOD) and EBT2 film. 
Materials and Methods: The beam output ratios (OR) for fields as 
small as 0.5 cm, were measured at depths of 5 cm and 10 cm in water 
with all detectors. Measurements were performed on the Elekta 
Synergy and the Varian Trubeam at a nominal 6 MV. The response of 
various detectors at small fields was compared between flattened and 
FFF beams, as well as to measurements on the Varian Novalis which 
uses a smaller stereotactic flattening filter. 
Results: For all linacs, the FOD agreed with the EBT2 film within 
measurement uncertainty for all field sizes, in both flattened and FFF 
beams. In the flattened beam, diode detectors showed an 
overresponse at small fields, as predicted in the literature (Ralston 
2012, McKerracher 1999). For the smallest field, the OR measured 
with a PTWe diode was 4.4% higher than that measured with the FOD. 
For the same irradiation in an FFF beam, however, the expected 
overresponse was not observed. The PTWe diode instead showed an 
underresponse of 2.0% relative to the FOD. 
 
 
Conclusions: These results support the conclusion of Scott (2012), 
derived from Monte Carlo simulation, that density correction factors 
for specific beam conditions may not be applicable to other beam 
conditions. Diode correction factors derived on-axis for flattened 
beams at a particular depth may not be applicable off-axis, for FFF 
conditions or at other depths. 
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Purpose/Objective: Flattening filter free(FFF) photon beams offer 
various advantages compared to flattened (FF) beams,e.g. a higher 
dose rate, reduced head scatter and leakage radiation. Forms of 
applications of FFF-beams are the treatment of tumors with small 
volumes in a hypofractionated stereotactic setup and the treatment of 
concave shaped tumors using IMRT or VMAT. For both, an accurate 
determination of output factors is mandatory. Therefore, influence of 
filtering on the measurement of output factors was investigated in 
this study.  
Materials and Methods: Several different ionization chambers and 
solid state detectors were investigated for small field dosimetry. An 
Elekta Precise Linac (Elekta, Crawley, UK) which is able to produce 
6MV and10MV FF and FFF photon beams was used in this study. The 
fields were shaped by a BrainLab M3 µMLC (BrainLAB AG, Heimstetten, 
Germany). The detectors were mounted in a Blue Phantom (IBA 
dosimetry, Germany) at SSD 95 in 5cm depth. For this study 10 
different square fields between 10x10cm² and 0.6x0.6cm² were 
investigated. All detectors were pre- irradiated with 1000MU. For 
each field 5 x 100MU were delivered. A Bragg Peak chamber (PTW, 
Germany) with its entrance window positioned at the water surface 
was used to verify the Linac output. The measured output factors 
were corrected for volume averaging effects which were determined 
in collaboration with the IAEA. Within this collaboration, output 
factors measured with the CC01 were compared to alanine 
measurements which agreed within 1% for all investigated field sizes. 
Hence, the measured output factors were normalized to those of the 
CC01. 
 
Tab. 1. Summary of detectors used 
for output factor measurements. 
Detector Type 
PTW    PinPoint 31014 
PTW    PinPoint 31016 
PTW    Diamond 60003 
PTW    MicroLion 31018 
IBA     CC13 
IBA     IC10 
IBA     CC04 
IBA     CC01 
IBA     PFD 
IBA     SFD 
IBA     EFD 
